Aytu BioScience expands MiOXSYS distribution network in Europe

Aytu BioScience expands MiOXSYS distribution network in Europe

ENGLEWOOD -- Aytu BioScience, Inc . (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced an exclusive... Read More

Friday July 14, 2017 0 comments Tags: Englewood, Aytu BioScience, Josh Disbrow, MiOXSYS, GryNumber Health

Paragon 28 launches PHANTOM Nail System for bunion correction

Paragon 28 launches PHANTOM Nail System for bunion correction

ENGLEWOOD -- Paragon 28 announced the launch of the PHANTOM Lapidus Intramedullary Nail, the first dedicated intramedullary nail designed specifically for use in correction of arthrodesis of... Read More

Monday June 26, 2017 0 comments Tags: Englewood, Paragon 28, Phantom

Aytu BioScience appoints Gregory Gould as permanent company CFO

Aytu BioScience appoints Gregory Gould as permanent company CFO

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced the hiring of ... Read More

Tuesday June 20, 2017 0 comments Tags: Aytu BioScience, Gregory Gould, Englewood, Josh Disbrow

Ampio appoints Tom Chilcott as interim CEO

Ampio appoints Tom Chilcott as interim CEO

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) today announced it has not renewed the employment agreement of Gregory Gould , Ampio's chief financial officer, which expired on ... Read More

Tuesday June 13, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Gregory Gould, Tom Chilcott, Aytu BioScience

Ampio Pharmaceuticals selling $6.3M in stock to fund Ampion clinical tests

Ampio Pharmaceuticals selling $6.3M in stock to fund Ampion clinical tests

ENGLEWOOD -- A mpio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announced it has entered into a securities purchase agreement with investors providing for the registered sale of approximately... Read More

Monday June 5, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Aytu BioScience acquires Nuelle female sexual health company

Aytu BioScience acquires Nuelle female sexual health company

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced the acquisition of... Read More

Wednesday May 10, 2017 0 comments Tags: Englewood, Aytu BioScience, Nuelle, Fiera, Josh Disbrow

Ampio initiates pivotal Ampion osteoarthritis trial

Ampio initiates pivotal Ampion osteoarthritis trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it has begun a single injection study to meet the unmet medical need of treating the severe pain and loss of function... Read More

Monday May 1, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Dr. David Bar-Or, Chris Ehrlich, Michael Macaluso

Aytu BioScience sells Primsol to Allegis Holdings

Aytu BioScience sells Primsol to Allegis Holdings

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced the divestiture of... Read More

Tuesday April 4, 2017 0 comments Tags: Englewood, Aytu BioScience, Allegis Holdings, Josh Disbrow, Natesto, MiOXSYS